Millipore Sigma Vibrant Logo

208743 Calpain Inhibitor XI - CAS 145731-49-3 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
145731-49-3C₂₆H₄₀N₄O₆

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
208743-5MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA cell-permeable dipeptidyl α-ketoamide that acts as a potent, highly selective, reversible, and active site inhibitor of calpain-1 and -2 (Ki = 140 nM and 41 nM, respectively). Weakly inhibits cathepsin B (Ki = 6.9 µM). Reported to have a neuroprotective role in the central nervous system following focal ischemia. Also protects against virus-induced apoptotic myocardial injury in mice.
      Catalogue Number208743
      Brand Family Calbiochem®
      SynonymsZ-L-Abu-CONH(CH₂)₃-morpholine
      References
      ReferencesBlomgren, K., et al. 2001. J. Biol. Chem. 276, 10191.
      DeBiasi, R.L., et al. 2001. J. Virol. 75, 351.
      Saatman, K.E., et al. 2000. J. Cereb. Blood Flow Metab. 20, 66.
      Stelmasiak, Z., et al. 2000. Med. Sci. Monit. 6, 426.
      Blomgren, K., et al. 1999. J. Biol. Chem. 274, 14046.
      James, T., et al. 1998. J. Neurosci. Res. 51, 218.
      Li, Z., et al. 1996. J. Med. Chem. 39, 4089.
      Saatman, K.E, et al. 1996. Proc. Natl. Acad. Sci. USA 93, 3428.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Bartus, R.T., et al. 1994. Stroke 25, 2265.
      Product Information
      CAS number145731-49-3
      ATP CompetitiveN
      FormWhite to off-white solid
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₂₆H₄₀N₄O₆
      Chemical formulaC₂₆H₄₀N₄O₆
      Hygroscopic Hygroscopic
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcalpain 1, calpain 2
      Primary Target K<sub>i</sub>140 nM and 41 nM, against calpain-1 and -2, respectively
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide SequenceZ-Leu-Abu-CONH(CH₂)₃-morpholine (Abu = α-aminobutyric acid)
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      208743-5MG 04055977202809

      Documentation

      Calpain Inhibitor XI - CAS 145731-49-3 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Calpain Inhibitor XI - CAS 145731-49-3 - Calbiochem Analysenzertifikate

      TitelChargennummer
      208743

      Literatur

      Übersicht
      Blomgren, K., et al. 2001. J. Biol. Chem. 276, 10191.
      DeBiasi, R.L., et al. 2001. J. Virol. 75, 351.
      Saatman, K.E., et al. 2000. J. Cereb. Blood Flow Metab. 20, 66.
      Stelmasiak, Z., et al. 2000. Med. Sci. Monit. 6, 426.
      Blomgren, K., et al. 1999. J. Biol. Chem. 274, 14046.
      James, T., et al. 1998. J. Neurosci. Res. 51, 218.
      Li, Z., et al. 1996. J. Med. Chem. 39, 4089.
      Saatman, K.E, et al. 1996. Proc. Natl. Acad. Sci. USA 93, 3428.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Bartus, R.T., et al. 1994. Stroke 25, 2265.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision04-May-2011 JSW
      SynonymsZ-L-Abu-CONH(CH₂)₃-morpholine
      DescriptionA cell-permeable dipeptidyl a-ketoamide that acts as a potent, highly selective, reversible, active site inhibitor of calpain-1 (Ki = 140 nM) and calpain-2 (Ki = 41 nM). Weakly inhibits cathepsin B (Ki = 6.9 µM). Shown to inhibit calpain-m-mediated degradation of neurofilament protein (NFP) (IC50 = 600 nM). Also shown to exhibit neuroprotective effects in the central nervous system following focal ischemia. Reported to protect against reovirus-induced myocarditis in mice.
      FormWhite to off-white solid
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number145731-49-3
      Chemical formulaC₂₆H₄₀N₄O₆
      Peptide SequenceZ-Leu-Abu-CONH(CH₂)₃-morpholine (Abu = α-aminobutyric acid)
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBlomgren, K., et al. 2001. J. Biol. Chem. 276, 10191.
      DeBiasi, R.L., et al. 2001. J. Virol. 75, 351.
      Saatman, K.E., et al. 2000. J. Cereb. Blood Flow Metab. 20, 66.
      Stelmasiak, Z., et al. 2000. Med. Sci. Monit. 6, 426.
      Blomgren, K., et al. 1999. J. Biol. Chem. 274, 14046.
      James, T., et al. 1998. J. Neurosci. Res. 51, 218.
      Li, Z., et al. 1996. J. Med. Chem. 39, 4089.
      Saatman, K.E, et al. 1996. Proc. Natl. Acad. Sci. USA 93, 3428.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Bartus, R.T., et al. 1994. Stroke 25, 2265.